CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-9.89%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.85B
AUM Growth
+$1.85B
(+5.4%)
Cap. Flow
+$374M
Cap. Flow
% of AUM
20.19%
Top 10 Holdings %
Top 10 Hldgs %
59.75%
Holding
37
New
9
Increased
14
Reduced
3
Closed
2
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$96.1M |
| 2 |
GSK
GSK
|
$76.4M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$58.4M |
| 4 |
Perrigo
PRGO
|
$46.5M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$43.7M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$93.3M |
| 2 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$62M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$52M |
| 4 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$27.4M |
| 5 |
Biogen
BIIB
|
$15M |
Sector Composition
| 1 | Healthcare | 95.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
26
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $19.5M | 0.92% |
+500,000
| New | +$19.5M |
|
27
Bausch Health
BHC
$2.72B
| $18.5M | 0.88% |
+1,000,000
| New | +$18.5M |
|
|
EGRX
28
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $11.7M | 0.56% |
291,600
| – | – |
|
29
DaVita
DVA
$9.72B
| $8.62M | 0.41% |
+167,528
| New | +$8.62M |
|
|
ELGX
30
DELISTED
Endologix Inc
ELGX
| $6.66M | 0.32% |
9,300,000
| – | – |
|
31
Sutro Biopharma
STRO
$85.6M
| $5.41M | 0.26% |
600,000
| – | – |
|
32
Surgery Partners
SGRY
$2.89B
| $1.57M | 0.07% |
160,084
+25,000
| +19% | +$245K |
|
33
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
0
| – | – |
|
34
Cardinal Health
CAH
$36B
| – | – |
0
| – | – |
|
35
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
|
KTWO
36
DELISTED
K2M Group Holdings, Inc
KTWO
| – | – |
-1,000,000
| Closed | -$27.4M |
|
|
EVHC
37
DELISTED
Envision Healthcare Holdings Inc
EVHC
| – | – |
-1,355,000
| Closed | -$62M |
|